Timothy P. Herbert Sells 9,832 Shares of Inspire Medical Systems (NYSE:INSP) Stock
Inspire Medical Systems (NYSE:INSP) CEO Timothy P. Herbert sold 9,832 shares of the business’s stock in a transaction that occurred on Monday, January 13th. The shares were sold at an average price of $80.10, for a total value of $787,543.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Shares of INSP opened at $81.25 on Thursday. Inspire Medical Systems has a one year low of $46.00 and a one year high of $82.15. The company has a market cap of $1.93 billion, a P/E ratio of -54.17 and a beta of 1.26. The company has a debt-to-equity ratio of 0.17, a current ratio of 13.42 and a quick ratio of 13.05. The firm has a 50 day simple moving average of $74.00 and a two-hundred day simple moving average of $66.09.
Inspire Medical Systems (NYSE:INSP) last announced its quarterly earnings results on Tuesday, November 5th. The company reported ($0.34) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.43) by $0.09. The company had revenue of $20.86 million during the quarter, compared to the consensus estimate of $19.15 million. Inspire Medical Systems had a negative net margin of 40.36% and a negative return on equity of 18.67%. The company’s revenue for the quarter was up 59.8% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.22) earnings per share. On average, analysts expect that Inspire Medical Systems will post -1.46 earnings per share for the current fiscal year.
Large investors have recently made changes to their positions in the company. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in shares of Inspire Medical Systems by 293.2% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 637 shares of the company’s stock worth $39,000 after buying an additional 475 shares in the last quarter. Evoke Wealth LLC acquired a new position in shares of Inspire Medical Systems during the third quarter worth $39,000. Marshall Wace North America L.P. acquired a new position in shares of Inspire Medical Systems during the first quarter worth $45,000. Royal Bank of Canada increased its holdings in shares of Inspire Medical Systems by 593.3% during the second quarter. Royal Bank of Canada now owns 1,040 shares of the company’s stock worth $63,000 after buying an additional 890 shares in the last quarter. Finally, FinTrust Capital Advisors LLC increased its holdings in shares of Inspire Medical Systems by 250.0% during the third quarter. FinTrust Capital Advisors LLC now owns 2,100 shares of the company’s stock worth $129,000 after buying an additional 1,500 shares in the last quarter. Institutional investors own 89.69% of the company’s stock.
About Inspire Medical Systems
Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
Further Reading: Guidelines for Successful Channel Trading
Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.